Genpharmasec Ltd

Genpharmasec Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Genpharmasec Ltd

₹ 2.00 0.00%
14 Jun - close price
genpharmasec.com BSE: 531592
About

Incorporated in 1992, Generic Pharmasec
Ltd deals in pharmaceutical activities /services and trades in equity shares[1]

Key Points

Business Overview:[1]
GPL started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and then shifted its business activities to buying, selling and distribution of pharmaceutical, medicinal and medicated preparations and also decided to deal in securities market. Currently, company is dealing in medical and diagnostics devices

Website BSE
  • Market Cap ₹ 111 Cr.
  • Current Price ₹ 2.00
  • High / Low ₹ 7.31 / 1.69
  • Stock P/E
  • Book Value ₹ 1.16
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE -0.33 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -30.0%
  • Promoter holding is low: 30.0%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Dec 2023 Mar 2024
6.22 6.38 10.20
6.01 6.37 10.21
Operating Profit 0.21 0.01 -0.01
OPM % 3.38% 0.16% -0.10%
0.06 0.14 0.31
Interest 0.06 0.00 0.16
Depreciation 0.01 0.12 0.03
Profit before tax 0.20 0.03 0.11
Tax % -420.00% -100.00% 345.45%
1.05 0.06 -0.27
EPS in Rs 0.02 0.00 -0.00
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
25.52 30.41
25.26 30.37
Operating Profit 0.26 0.04
OPM % 1.02% 0.13%
0.10 0.66
Interest 0.06 0.41
Depreciation 0.02 0.04
Profit before tax 0.28 0.25
Tax % -300.00% 168.00%
1.12 -0.17
EPS in Rs 0.02 -0.00
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -112%
Stock Price CAGR
10 Years: 9%
5 Years: -19%
3 Years: -28%
1 Year: -12%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 0%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
Equity Capital 27.69 55.37
Reserves -12.36 9.02
3.08 3.89
1.47 2.85
Total Liabilities 19.88 71.13
0.10 0.84
CWIP 0.00 0.00
Investments 0.95 19.45
18.83 50.84
Total Assets 19.88 71.13

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
-3.06 -4.10
0.36 -27.35
3.08 47.86
Net Cash Flow 0.39 16.41

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
Debtor Days 81.67 109.22
Inventory Days 151.06 133.17
Days Payable 21.38 35.85
Cash Conversion Cycle 211.34 206.54
Working Capital Days 221.40 231.89
ROCE %

Shareholding Pattern

Numbers in percentages

8 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
59.96% 59.96% 59.96% 59.96% 59.96% 59.96% 59.96% 59.96% 59.96% 59.96% 59.96% 29.98%
40.04% 40.04% 40.04% 40.04% 40.04% 40.03% 40.04% 40.03% 40.03% 40.04% 40.04% 70.02%
No. of Shareholders 9,55917,12124,13454,00753,40453,26651,43549,76048,86854,45889,4381,08,137

Documents

Announcements

Annual reports